154 related articles for article (PubMed ID: 37792628)
1. Study of the PI3K/Akt/mTOR signaling pathway in vitro and molecular docking analysis of periplocin inhibits cell cycle progression and induces apoptosis in MDA-MB-231.
Liu X; Liu J; Yan B; Quan Z; Wang X; Ma Y; Alarfaj AA; Yan L
Environ Toxicol; 2024 Jan; 39(1):444-456. PubMed ID: 37792628
[TBL] [Abstract][Full Text] [Related]
2. Total saponins of Bolbostemma paniculatum (maxim.) Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway.
Dou JW; Shang RG; Lei XQ; Li KL; Guo ZZ; Ye K; Yang XJ; Li YW; Zhou YY; Yao J; Huang Q
BMC Complement Altern Med; 2019 Nov; 19(1):304. PubMed ID: 31703679
[TBL] [Abstract][Full Text] [Related]
3. Sodium alginate encapsulated iron oxide decorated with thymoquinone nanocomposite induces apoptosis in human breast cancer cells via PI3K-Akt-mTOR pathway.
Alzahrani B; Elderdery AY; Alsrhani A; Alzerwi NAN; Althobiti MM; Elkhalifa AME; Rayzah M; Idrees B; Kumar SS; Mok PL
Int J Biol Macromol; 2023 Jul; 244():125054. PubMed ID: 37245766
[TBL] [Abstract][Full Text] [Related]
4. Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway
Meng M; Yang Q; Ouyang Z; Yang Q; Wu X; Huang Y; Su Y; Chen S; Chen W
Acta Pharm; 2023 Mar; 73(1):75-90. PubMed ID: 36692465
[TBL] [Abstract][Full Text] [Related]
5. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
Tohkayomatee R; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 May; 27(11):. PubMed ID: 35684480
[TBL] [Abstract][Full Text] [Related]
6. DMC triggers MDA-MB-231 cells apoptosis via inhibiting protective autophagy and PI3K/AKT/mTOR pathway by enhancing ROS level.
Jiang Y; Xu S; Guo M; Lu Z; Wei X; An F; Xin X
Toxicol In Vitro; 2024 May; 97():105809. PubMed ID: 38521250
[TBL] [Abstract][Full Text] [Related]
7. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMT.
Guefack MF; Talukdar D; Mukherjee R; Guha S; Mitra D; Saha D; Das G; Damen F; Kuete V; Murmu N
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117093. PubMed ID: 37634746
[TBL] [Abstract][Full Text] [Related]
8. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
[TBL] [Abstract][Full Text] [Related]
9. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
10. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of safranal against colon carcinoma is due to induction of apoptosis and G2/M cell cycle arrest mediated by suppression of mTOR/PI3K/Akt pathway.
Zhang Y; Zhao Y; Guo J; Cui H; Liu S
J BUON; 2018; 23(3):574-578. PubMed ID: 30003721
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
[TBL] [Abstract][Full Text] [Related]
13. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation.
Zhang D; Zhang Q; Zheng Y; Lu J
J Ethnopharmacol; 2020 Sep; 259():112984. PubMed ID: 32446927
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
15. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
16. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).
Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J
Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520
[TBL] [Abstract][Full Text] [Related]
17. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway.
Sun Y; Xu Y; Xu J; Lu D; Wang J
Int J Clin Exp Pathol; 2015; 8(8):9081-8. PubMed ID: 26464650
[TBL] [Abstract][Full Text] [Related]
18. Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway.
Won YS; Seo KI
Food Chem Toxicol; 2020 Jan; 135():110863. PubMed ID: 31604113
[TBL] [Abstract][Full Text] [Related]
19. Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells.
Kaushik S; Shyam H; Sharma R; Balapure AK
Phytomedicine; 2018 Feb; 40():116-124. PubMed ID: 29496164
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.
Qu J; Sun Y; Yang L; Niu X; Li L
J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
